Table 3.
Site of administration | Dose (μg/kg) | Feeding condition | Circadian phase | Species | Effect on food intake | Reference |
---|---|---|---|---|---|---|
icv | 1.9 | ad lib | light, dark | rats | ↑ | [146] |
icv | 9.1–91 | ad lib | light | mice | = | [9] |
icv | 91 | fasted | light | mice | ↓ | [9] |
| ||||||
iv | 14.4–48 | ad lib | light | rats | = | [146] |
| ||||||
ip | 128 | ad lib | light | mice | = | [146] |
ip | 274 | fasted | light | mice | ↓ | [9] |
ip | 64 | ad lib | light | rats | = | [31] |
ip | 64 | fasted | light | rats | ↓ | [31] |
ip | 64 | ad lib | dark | rats | ↓ | [31] |
ip | 960 | ad lib, fasted | ns | mice | = | [104] |
ip | 64–125 | ad lib, fasted | light | rats | = | [66] |
icv: intracerebroventricular, iv: intravenous, ip: intraperitoneal, ad lib: ad libitum fed, fas: fasted, ns: not specified